Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Persistent Asthma”

40 trials

Showing 20 of 40 results

Testing effectiveness (Phase 2)Study completedNCT00330070
What this trial is testing

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Who this might be right for
Asthma
Inflazyme Pharmaceuticals Ltd 200
Large-scale testing (Phase 3)Study completedNCT00401596
What this trial is testing

Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Who this might be right for
Asthma
Genentech, Inc. 1,899
Large-scale testing (Phase 3)Study completedNCT00563056
What this trial is testing

An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

Who this might be right for
Asthma Bronchiale
Mundipharma Research Limited 227
Testing effectiveness (Phase 2)Study completedNCT00280683
What this trial is testing

Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma

Who this might be right for
Asthma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00096616
What this trial is testing

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 113
Testing effectiveness (Phase 2)Study completedNCT04773678
What this trial is testing

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Who this might be right for
Moderate to Severe Persistent Asthma
Connect Biopharm LLC 322
Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Testing effectiveness (Phase 2)Study completedNCT00873860
What this trial is testing

Study to Evaluate the Safety and Efficacy of CAT-354

Who this might be right for
Asthma
MedImmune LLC 357
Not applicableStudy completedNCT07787507
What this trial is testing

Withania Somnifera for Moderate-to-Severe Persistent Asthma

Who this might be right for
Asthma
Aligarh Muslim University 120
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Large-scale testing (Phase 3)Study completedNCT04233190
What this trial is testing

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Who this might be right for
Asthma Copd
Eurofarma Laboratorios S.A. 472
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Large-scale testing (Phase 3)Study completedNCT06657066
What this trial is testing

EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

Who this might be right for
Asthma Patients
King Edward Medical University 74
Large-scale testing (Phase 3)Study completedNCT01340209
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 285
Large-scale testing (Phase 3)Study completedNCT00529529
What this trial is testing

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 805
Not applicableStudy completedNCT00282516
What this trial is testing

Asthma In-Home Monitoring (AIM) Trial

Who this might be right for
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Tripler Army Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Study completedNCT00254956
What this trial is testing

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Who this might be right for
Respiratory Tract DiseasesRespiratory HypersensitivityAsthma
Sanofi 1,568
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Testing effectiveness (Phase 2)Study completedNCT01311661
What this trial is testing

Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 206
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation